These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 3154815)
1. Glucose, insulin and C-peptide kinetics during an oral glucose tolerance test in patients with chronic liver disease. Min YK; Suh KI; Choi SJ; Lee HK; Kim CY; Koh CS; Min HK Korean J Intern Med; 1987 Jan; 2(1):37-41. PubMed ID: 3154815 [TBL] [Abstract][Full Text] [Related]
2. Glucose, insulin and C-peptide kinetics during intravenous glucose tolerance test in chronic liver disease. Lee KU; Rhee BD; Lee HK; Kim CY; Koh CS; Min HK Diabetes Res Clin Pract; 1987; 3(3):161-6. PubMed ID: 3297592 [TBL] [Abstract][Full Text] [Related]
3. [Insulin and C-peptide in chronic liver diseases during oral glucose tolerance testing]. Oehler G; Knecht M; Bleyl H; Matthes KJ Dtsch Med Wochenschr; 1984 Feb; 109(7):253-7. PubMed ID: 6365504 [TBL] [Abstract][Full Text] [Related]
4. [Plasma insulin, glucose and C-peptide responses to oral glucose tolerance test in patients with liver disease]. Zhonghua Yi Xue Za Zhi; 1982 Nov; 62(11):657-61. PubMed ID: 6819876 [No Abstract] [Full Text] [Related]
6. [Monitoring glucose tolerance and blood insulin in patients with chronic liver disease with a 5 year clinical history]. Oehler G; Bleyl H; Matthes K Med Welt; 1983 Sep; 34(37):995-7. PubMed ID: 6355750 [No Abstract] [Full Text] [Related]
7. [Correlation of the changes of sugar metabolism and those of blood insulin and glucagon levels in liver diseases. Part 1. The responses to oral glucose administration (author's transl)]. Kikuchi A; Kihara A Nihon Shokakibyo Gakkai Zasshi; 1978 Nov; 75(11):1744-55. PubMed ID: 731982 [No Abstract] [Full Text] [Related]
8. [C-peptide and insulin ratio in patients with juvenile dyspituitarism in varying symptomatology]. Malygina EV; Belovalova IM; Starkova NT; Starosel'tseva LK Probl Endokrinol (Mosk); 1992; 38(2):17-20. PubMed ID: 1513765 [TBL] [Abstract][Full Text] [Related]
9. [The effect of age on the response of insulin and C-peptide to oral glucose in non-insulin-dependent diabetes]. Bonora E; Moghetti P; Querena M; Coscelli C; Butturini U; Muggeo M Minerva Endocrinol; 1985; 10(3):165-9. PubMed ID: 3913861 [No Abstract] [Full Text] [Related]
10. Blood glucose, serum thyroid hormones, insulin, C-peptide and C-peptide/insulin ratio in hyperthyroid patients. Yamada T; Shirota T; Aizawa T; Takasu N Horm Metab Res; 1991 Oct; 23(10):504-5. PubMed ID: 1761283 [No Abstract] [Full Text] [Related]
11. [-Glucose, insulin and C-peptide kinetics during tocolysis with oral fenoterol-]. Günter HH; Nitschmann A; Balks HJ; Wedeking-Schöhl H; Niesert S Gynakol Geburtshilfliche Rundsch; 1995; 35(4):215-20. PubMed ID: 8646005 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the metabolic effects of mixed meal and standard oral glucose tolerance test on glucose, insulin and C-peptide response in healthy, impaired glucose tolerance, mild and severe non-insulin-dependent diabetic subjects. Marena S; Montegrosso G; De Michieli F; Pisu E; Pagano G Acta Diabetol; 1992; 29(1):29-33. PubMed ID: 1520903 [TBL] [Abstract][Full Text] [Related]
13. Human plasma C-peptide immunoreactivity: its correlation with immunoreactive insulin in diabetes, and chronic liver and renal diseases. Kajinuma H; Kanazawa Y; Sando H; Hayashi M; Kawazu S; Kosaka K Endocrinol Jpn; 1979 Feb; 26(1):65-73. PubMed ID: 436802 [TBL] [Abstract][Full Text] [Related]
14. Decreased plasma C-peptide to insulin molar ratio after oral glucose in elderly subjects. Ikeda T; Fujiyama K; Takeuchi T; Honda M; Mokuda O; Tominaga M; Mashiba H Exp Clin Endocrinol; 1989; 94(3):351-6. PubMed ID: 2698354 [TBL] [Abstract][Full Text] [Related]
15. [Plasma glucose, insulin and C-peptide responses in normal subjects to 100, 75 and 50 grams of glucose load during glucose tolerance test]. Zhonghua Yi Xue Za Zhi; 1982 Nov; 62(11):648-50. PubMed ID: 6819874 [No Abstract] [Full Text] [Related]
16. Influence of ageing on glucose homeostasis. Jackson RA; Blix PM; Matthews JA; Hamling JB; Din BM; Brown DC; Belin J; Rubenstein AH; Nabarro JD J Clin Endocrinol Metab; 1982 Nov; 55(5):840-8. PubMed ID: 6749877 [No Abstract] [Full Text] [Related]
17. Growth hormone, insulinlike growth factor-1, and insulinlike growth factor binding proteins 1 and 3 in chronic liver disease. Donaghy A; Ross R; Gimson A; Hughes SC; Holly J; Williams R Hepatology; 1995 Mar; 21(3):680-8. PubMed ID: 7533122 [TBL] [Abstract][Full Text] [Related]
18. Calcium antagonists and hormone release. VIII. Effects of verapamil infusion on C-peptide to insulin molar ratio in normal subjects and obese subjects with normal glucose tolerance. De Marinis L; Mancini A; Zuppi P; Sammartano L; Valle D; Fiumara C; Sandric S; Folli G Diabetes Res; 1992 Jan; 19(1):9-16. PubMed ID: 1468187 [TBL] [Abstract][Full Text] [Related]
19. [Studies on the introduction of 75g oral glucose tolerance test in various liver diseases]. Nagamine T; Yamada S; Saeki S; Takahasahi H; Abe T; Sakurai S; Yamada T; Yuasa K; Ichikawa K; Takezawa J Nihon Shokakibyo Gakkai Zasshi; 1984 Jun; 81(6):1388-97. PubMed ID: 6381822 [No Abstract] [Full Text] [Related]
20. [Plasma glucose, serum insulin and C-peptide in patients with various stages of chronic renal failure]. Jovanović D; Djukanović Lj; Veljović R; Manojlović D Srp Arh Celok Lek; 1994; 122(3-4):59-61. PubMed ID: 17972808 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]